Inventor
BROUGH DOUGLAS E
US57 patents
⚠️ This page may combine multiple inventors who share the name “BROUGH DOUGLAS E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENVEC INC
45 patentsUS6113913ASep 5, 2000
Recombinant adenovirus
GENVEC INC192 citations99
US5965541AOct 12, 1999
Vectors and methods for gene transfer to cells
GENVEC INC163 citations99
US5846782ADec 8, 1998
Targeting adenovirus with use of constrained peptide motifs
GENVEC INC336 citations99
US5731190AMar 24, 1998
Penton base protein and methods of using same
GENVEC INC123 citations99
US5712136AJan 27, 1998
Adenoviral-mediated cell targeting commanded by the adenovirus penton base protein
GENVEC INC140 citations99
US5994106ANov 30, 1999
Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus
GENVEC INC405 citations98
US5851806ADec 22, 1998
Complementary adenoviral systems and cell lines
GENVEC INC290 citations98
US7195896B2Mar 27, 2007
Complementary adenoviral vector systems and cell lines
GENVEC INC74 citations97
US6482616B1Nov 19, 2002
RCA-free adenoviral vector system and propagation method
GENVEC INC97 citations97
US5559099ASep 24, 1996
Penton base protein and methods of using same
GENVEC INC269 citations97
US6677156B2Jan 13, 2004
Non-adenoviral gene product-based complementing cells for adenoviral vectors
GENVEC INC46 citations96
US6660521B2Dec 9, 2003
Use of trans-activation and CIS-activation to increase the persistence of a transgene in an at least E4-deficient adenovirus
GENVEC INC73 citations96
US6465253B1Oct 15, 2002
Vectors and methods for gene transfer to cells
GENVEC INC53 citations96
US6951755B2Oct 4, 2005
Vectors and methods for gene transfer
GENVEC INC20 citations93
US6649373B2Nov 18, 2003
Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene
GENVEC INC16 citations93
US6225113B1May 1, 2001
Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene in an at least E4-deficient adenovirus
GENVEC INC33 citations93
US6821775B1Nov 23, 2004
Viral vector encoding pigment epithelium-derived factor
GENVEC INC24 citations92
US6682929B2Jan 27, 2004
Adenovector complementing cells
GENVEC INC45 citations92
US6475757B2Nov 5, 2002
Plasmids for construction of eukaryotic viral vectors
GENVEC INC23 citations92
US6329200B1Dec 11, 2001
Plasmids for construction of eukaryotic viral vectors
GENVEC INC29 citations92
US6440728B1Aug 27, 2002
Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus
GENVEC INC23 citations90
US10272162B2Apr 30, 2019
Affenadenovirus (gorilla) or adenoviral vectors and methods of use
GENVEC INC8 citations84
US10059962B2Aug 28, 2018
Simian (gorilla) adenovirus or adenoviral vectors and methods of use
GENVEC INC5 citations84
US9617560B2Apr 11, 2017
Simian (gorilla) adenovirus or adenoviral vectors and methods of use
GENVEC INC7 citations84
US9790519B2Oct 17, 2017
Modified serotype 28 adenoviral vectors
GENVEC INC8 citations82
US6913927B2Jul 5, 2005
Non-adenoviral gene product-based complementing cells for adenoviral vectors
GENVEC INC5 citations74
US9580476B2Feb 28, 2017
Adenoviral vector-based respiratory syncytial virus (RSV) vaccine
GENVEC INC3 citations73
US9388429B2Jul 12, 2016
Method for propagating adenoviral vectors encoding inhibitory gene products
GENVEC INC3 citations73
US6579522B1Jun 17, 2003
Replication deficient adenoviral TNF vector
GENVEC INC11 citations70
US9676824B2Jun 13, 2017
Herpes simplex virus vaccine
GENVEC INC4 citations68
US6998263B2Feb 14, 2006
Methods of preparing and using a viral vector library
GENVEC INC3 citations63
US11359214B2Jun 14, 2022
Simian (gorilla) adenovirus or adenoviral vectors and methods of use
GENVEC INC0 citations62
US11034975B2Jun 15, 2021
Affenadenovirus (gorilla) or adenoviral vectors and methods of use
GENVEC INC0 citations62
US9629906B2Apr 25, 2017
Affenadenovirus (gorilla) or adenoviral vectors and methods of use
GENVEC INC1 citations62
US9233153B2Jan 12, 2016
Affenadenovirus (gorilla) or adenoviral vectors and methods of use
GENVEC INC1 citations62
US10947560B2Mar 16, 2021
Modified serotype 28 adenoviral vectors
GENVEC INC0 citations61
US7070930B2Jul 4, 2006
Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus
GENVEC INC2 citations60
US11279951B2Mar 22, 2022
Adenoviral vector encoding human atonal homolog-1 (HATH1)
GENVEC INC0 citations58
US11155832B2Oct 26, 2021
Adenovectors for delivery of therapeutic genetic material into T cells
GENVEC INC0 citations53
US10792376B2Oct 6, 2020
Affenadenovirus (gorilla) or adenoviral vectors and methods of use
GENVEC INC0 citations52
US10787682B2Sep 29, 2020
Simian (gorilla) adenovirus or adenoviral vectors and methods of use
GENVEC INC0 citations52
US10640776B2May 5, 2020
Method for propagating adenoviral vectors encoding inhibitory gene products
GENVEC INC0 citations52
US10260074B2Apr 16, 2019
Affenadenovirus (gorilla) or adenoviral vectors and methods of use
GENVEC INC0 citations52
US9725738B2Aug 8, 2017
Affenadenovirus (gorilla) or adenoviral vectors and methods of use
GENVEC INC0 citations52
US6458578B1Oct 1, 2002
Recombinant cell line produces adenoviral gene products E1 and DEF-A, and/or DEF-B
GENVEC INC0 citations52
PRECIGEN INC
3 patentsBRUDER JOSEPH T
1 patentBROUGH DOUGLAS E
1 patentShowing the top 50 of 57 patents by PatentIndex Score.